349 related articles for article (PubMed ID: 28640844)
1. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.
Agemi Y; Shimokawa T; Sasaki J; Miyazaki K; Misumi Y; Sato A; Aida S; Ishii M; Nakamura Y; Naoki K; Okamoto H
PLoS One; 2019; 14(1):e0210499. PubMed ID: 30653558
[TBL] [Abstract][Full Text] [Related]
3. First validation of the G-8 geriatric screening tool in older patients with glioblastoma.
Deluche E; Leobon S; Lamarche F; Tubiana-Mathieu N
J Geriatr Oncol; 2019 Jan; 10(1):159-163. PubMed ID: 30037767
[TBL] [Abstract][Full Text] [Related]
4. Performance of two geriatric screening tools in older patients with cancer.
Kenis C; Decoster L; Van Puyvelde K; De Grève J; Conings G; Milisen K; Flamaing J; Lobelle JP; Wildiers H
J Clin Oncol; 2014 Jan; 32(1):19-26. PubMed ID: 24276775
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma.
Yamada SI; Hasegawa T; Okuyama K; Yamakawa N; Okura M; Hashidume M; Yanamoto S; Akashi M; Kirita T; Umeda M; Kurita H
Clin Oral Investig; 2020 Jun; 24(6):1953-1961. PubMed ID: 31410674
[TBL] [Abstract][Full Text] [Related]
6. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
Schulkes KJG; Souwer ETD; van Elden LJR; Codrington H; van der Sar-van der Brugge S; Lammers JJ; Portielje JEA; van den Bos F; Hamaker ME
Clin Lung Cancer; 2017 Nov; 18(6):660-666.e1. PubMed ID: 28320638
[TBL] [Abstract][Full Text] [Related]
8. Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
Karuturi MS; Cappelleri JC; Blum JL; Patel K; Telivala B; McCune S; Cuevas JD; Lakhanpal S; Montelongo MZ; Wang Y; Tripathy D; Rocque GB
J Geriatr Oncol; 2024 Jan; 15(1):101670. PubMed ID: 38061288
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
[TBL] [Abstract][Full Text] [Related]
10. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
11. Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer.
Fagard K; Casaer J; Wolthuis A; Flamaing J; Milisen K; Lobelle JP; Wildiers H; Kenis C
J Geriatr Oncol; 2017 Sep; 8(5):320-327. PubMed ID: 28781062
[TBL] [Abstract][Full Text] [Related]
12. Three Years Survival of Elderly Cancer Patients in Indonesia: Do We Need a Different Approach?
Sutandyo N; Kurniawati SA; Siregar NN; Sari NK
Acta Med Indones; 2020 Jan; 52(1):39-46. PubMed ID: 32291370
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
Arslan D; Tural D; Koca T; Tastekin D; Kaymak Cerkesli A; Basaran H; Gunduz S; Murat Tatli A; Sezgin Goksu S; Uysal M; Kargi A; Kargi B; Koral L; Ibrahim Bassorgun C; Unal D; Mutlu H; Senol Coskun H; Ozdogan M; Bozcuk H
J BUON; 2015; 20(2):573-9. PubMed ID: 26011352
[TBL] [Abstract][Full Text] [Related]
14. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
[TBL] [Abstract][Full Text] [Related]
15. Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
Käsmann L; Taugner J; Eze C; Roengvoraphoj O; Dantes M; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Anticancer Res; 2019 Sep; 39(9):5077-5081. PubMed ID: 31519618
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
[TBL] [Abstract][Full Text] [Related]
17. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy.
Song T; Wan Q; Yu W; Li J; Lu S; Xie C; Wang H; Fang M
Oncotarget; 2017 Nov; 8(58):98974-98984. PubMed ID: 29228742
[TBL] [Abstract][Full Text] [Related]
19. Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
Choi YW; Ahn MS; Jeong GS; Lee HW; Jeong SH; Kang SY; Park JS; Choi JH; Lee SY
Lung Cancer; 2015 Feb; 87(2):155-61. PubMed ID: 25488862
[TBL] [Abstract][Full Text] [Related]
20. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
Vivaldi C; Caparello C; Musettini G; Pasquini G; Catanese S; Fornaro L; Lencioni M; Falcone A; Vasile E
Int J Cancer; 2016 Aug; 139(4):938-45. PubMed ID: 27038273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]